Intraocular Drug Delivery System

Introduction 10 million intraocular lenses are implanted each year worldwide in which infection is a major concern. In order to prevent serious infections that can lead to blindness, antibiotic drops are prescribed to be administered after surgery by the patient. Antibiotics are applied to the eye using eye-drops that are difficult and often uncomfortable to administer. These difficulties lead to patient compliance problems and eye infections. Technology description Researchers at the University of Washington have developed a drug delivery strategy that will provide optimal and consistent dosage of antibiotics for up to two weeks. The antibiotic is embedded in a matrix and applied to the intraocular lens
(IOL) by the surgeon immediately prior to inserting the IOL in the eye. Business opportunity This technology has potential to solve a clear clinical need in ophthalmologic surgery. The materials are low cost and are recognized by the FDA as generally safe. Companies in the ophthalmologic surgery market may be able to improve their intraocular lenses by incorporating this technology into their product lines. Intellectual property position The UW has filed a patent on this technology.

Type of Offer: Licensing



« More Engineering Patents
« More Medical Patents

---